Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy. - Wikidata - wikimedia - TriplyDB

Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy.

Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy.

http://www.wikidata.org/entity/Q37649650

about

Progresses towards safe and efficient gene therapy vectors Strategies and Advancements in Harnessing the Immune System for Gastric Cancer Immunotherapy Trial Watch:: Oncolytic viruses for cancer therapy Tumor Restrictive Suicide Gene Therapy for Glioma Controlled by the FOS Promoter Trial Watch-Oncolytic viruses and cancer therapy A dual-regulated oncolytic adenovirus carrying TAp63 gene exerts potent antitumor effect on colorectal cancer cells Sulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal model Targeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models.CDC20 maintains tumor initiating cells.Use of a Novel Integrase-Deficient Lentivirus for Targeted Anti-Cancer Therapy With Survivin Promoter-Driven Diphtheria Toxin A The cytomegalovirus protein UL138 induces apoptosis of gastric cancer cells by binding to heat shock protein 70.Radiofrequency hyperthermia promotes the therapeutic effects on chemotherapeutic-resistant breast cancer when combined with heat shock protein promoter-controlled HSV-TK gene therapy: Toward imaging-guided interventional gene therapy.Targeting Hsp70: A possible therapy for cancer.Exogenously delivered heat shock protein 70 displaces its endogenous analogue and sensitizes cancer cells to lymphocytes-mediated cytotoxicity.Strong antitumor efficacy of a pancreatic tumor-targeting oncolytic adenovirus for neuroendocrine tumors.Oncolytic Adenoviruses in Gastrointestinal Cancers.Oncolytic virotherapy in upper gastrointestinal tract cancers.Promoter-Operating Targeted Expression of Gene Therapy in Cancer: Current Stage and Prospect.

P2860

Q26781432-7F8E9B79-6A97-4954-A4F7-61F4AF5F158F Q26823515-0FD0933C-8D90-4E57-8BB7-674423580EAB Q27021951-A4E62ACB-197C-410D-A778-20C285343086 Q27342367-A177F4CC-AA78-473A-AE05-4E7672A301DB Q28072347-1B413FBB-EFC6-482B-8DED-4EB8D89F3882 Q33850296-4AB74ADF-4576-4AFA-9342-FE0C80AFE9F8 Q34104125-ED86B549-2046-4CF7-B286-130CF0BCB064 Q35176018-44D424CD-EAFB-459D-B274-5ADCAC88E011 Q35955263-80F01794-9B18-4716-BED5-5102AB0F763F Q36194681-E23B3D61-8CA3-484E-A4AB-462689B2771F Q36905736-24BC4D48-004A-4203-9797-C4233809B0F5 Q37662190-B0319240-D165-45D1-B0F6-A38183AB2972 Q38742944-25308E58-061D-4B26-9A3F-0192B3F45C69 Q38998531-6EAC39F7-4A69-4DDE-B2C6-D0510847FDA3 Q41931526-DB8FE84F-421F-4661-B8EB-248C59A81877 Q52726850-CEB830C5-2121-45DA-9E40-48B264C8ECD5 Q54242367-BFCA3FBD-3DA7-419D-B95D-11935C812DF6 Q55239952-681D8612-ED5A-4692-82B0-A46EEF4FEAFE

P2860

Survivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy.

http://www.wikidata.org/entity/Q37649650

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on January 2014

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Survivin promoter-regulated on ...... gastric cancer immunotherapy.

@en

Survivin promoter-regulated on ...... gastric cancer immunotherapy.

@nl

type

label

Survivin promoter-regulated on ...... gastric cancer immunotherapy.

@en

Survivin promoter-regulated on ...... gastric cancer immunotherapy.

@nl

prefLabel

Survivin promoter-regulated on ...... gastric cancer immunotherapy.

@en

Survivin promoter-regulated on ...... gastric cancer immunotherapy.

@nl

P1433

Q37649650-68A2E926-B0AE-4E83-9920-B63733D2612D

P1476

Q37649650-D3896A44-EDC0-4E6E-928F-3DE3D891A304

P2093

Q37649650-38E4A110-B7E9-43BE-9548-15AC8F0F9A4D

Q37649650-52846BBB-B095-44FF-97DB-6579E4C7B3B3

Q37649650-5C38CF99-0FB3-4513-9E01-B8B109A8F1B6

Q37649650-6F72A07F-7DFF-475A-B811-7630159722C3

Q37649650-9BA5FA2E-EDC0-4008-BEB0-07C4EE941D7B

Q37649650-AA0974FE-61C4-44EB-B9A4-08F3EEF2CEFF

Q37649650-B21FEB97-6E3E-4B8C-ACDF-41F626792E2E

Q37649650-BECE58F4-D3CA-4EAF-A177-3FA58A2877AA

Q37649650-CE2B134A-9ED3-4706-852D-F1E56A018A98

Q37649650-D0F14699-A229-4D5C-9A4B-E523E4FF611A

P2860

Q37649650-0079BF17-672F-4D9D-8C54-6C01EE97F126

Q37649650-0112402C-9441-4388-B4AA-3073E62AB85B

Q37649650-07D6E5C4-FD32-40F0-9366-E41880E968D7

Q37649650-0F08F46F-24CA-4DF5-B6F9-7808A54228FB

Q37649650-0F2C3AE5-2232-4FA3-91FD-9D92D50A0EF1

Q37649650-10DA1536-D1B0-41A9-81B8-A20E68141A54

Q37649650-3C60A3C7-3011-4918-AEA2-4E646AFEEA04

Q37649650-43F9E1DD-6CAE-45CF-A447-50EB590FBD64

Q37649650-4C43F5FA-8EFF-4B22-AEEA-05B851D26F80

Q37649650-5023CEDD-F33B-4348-B877-61D07C4FD8C1

P304

Q37649650-07425BA1-30E1-40AB-8E9E-754A31EBD633

P31

Q37649650-EDC91576-A775-4C3B-970A-41C8B743417F

P356

Q37649650-B54484E9-1A99-4453-A44E-AFDB684DB934

P407

Q37649650-79C4EF5D-4E37-4146-9703-803315661CFC

P433

Q37649650-DF5719D6-661B-4B16-9B38-18065A337D0E

P478

Q37649650-E42E875F-7978-4569-9B00-61C32C1C225E

P577

Q37649650-558F8AB2-0F51-4DAF-B4A1-3AF5987A8E3A

P5875

Q37649650-4C4BECF1-A90F-4010-80BD-4C1704A88EFC

P698

Q37649650-E1D570B0-917B-45AE-950F-A001407A1196

P921

Q37649650-3B6C9A71-412B-400E-9452-3C462D38DC5E

Q37649650-7FF4D2DF-D3BF-41F6-B70D-49440019F6EF

Q37649650-9CB72BD0-BD03-49F6-85ED-FE4629D25CED

P932

Q37649650-4E688FAF-DB76-48DC-ABC1-68D959900D32

P356

ONCOTARGET.1430

P1433

P1476

Survivin promoter-regulated on ...... gastric cancer immunotherapy.

@en

P2093

Changqing Su

http://www.w3.org/2001/XMLSchema#string

Huanzhang Hu

http://www.w3.org/2001/XMLSchema#string

Huizhen Hu

http://www.w3.org/2001/XMLSchema#string

Juming Ma

http://www.w3.org/2001/XMLSchema#string

Qizhe Song

http://www.w3.org/2001/XMLSchema#string

Weidan Ji

http://www.w3.org/2001/XMLSchema#string

Weiguo Wang

http://www.w3.org/2001/XMLSchema#string

Weiqun Mei

http://www.w3.org/2001/XMLSchema#string

Xiaoya Li

http://www.w3.org/2001/XMLSchema#string

Yan Yan

http://www.w3.org/2001/XMLSchema#string

P2860

Plasmodium falciparum-infected erythrocytes induce granzyme B by NK cells through expression of host-Hsp70.

Interaction of heat shock proteins with peptides and antigen presenting cells: chaperoning of the innate and adaptive immune responses.

Intravenous delivery of a multi-mechanistic cancer-targeted oncolytic poxvirus in humans.

OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma.

OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma.

Targeting survivin in cancer: novel drug development approaches.

Increased endoplasmic reticulum stress response is involved in clopidogrel-induced apoptosis of gastric epithelial cells

Intracellular and extracellular functions of heat shock proteins: repercussions in cancer therapy.

The HSP70 family and cancer

Trial watch: Oncolytic viruses for cancer therapy

P304

150-160

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.18632/ONCOTARGET.1430

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

5

http://www.w3.org/2001/XMLSchema#string

P577

2014-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

259960258

http://www.w3.org/2001/XMLSchema#string

P698

24473833

http://www.w3.org/2001/XMLSchema#string

P921

oncolytic virus

P932

3960197

http://www.w3.org/2001/XMLSchema#string